Introduction: The aim of this study is to assess the prevalence and molecular characterization of uropathogenic Extended spectrum β-lactamases (ESBLs) producing Escherichia coli. Methodology: During 3 years, all hospitalized patients at the University-affiliated hospital of Tlemcen and presenting urinary tract infections caused by E. coli were considered as potential study participants. These E. coli isolates were examined phenotypically for ESBL production. ESBL strains were subjected to antimicrobial susceptibility testing and were investigated for the presence of plasmid mediated quinolone resistance genes, 16SrRNA methylase genes and virulence genes by using conventional PCR and DNA sequencing. The molecular characterization of ESBL strains was established by phylogenetic grouping method and ERIC-PCR. Results: The overall prevalence of ESBL was 32.5%. The blaCTX-M-15 was the most frequently detected in ESBL isolates, followed by blaCTX-M-14, blaCTX-M-28, blaCTX-M-1 and blaSHV-12 respectively. The plasmid-mediated quinolone resistance genes were detected in the 15 ESBL strains with the aac(6')-Ib-cr gene was the most detected followed by qnrB1 and qnrA1 gene respectively. Among the 22 ESBL isolates resistant to gentamicin and amikacin, the 16SrRNA methylase genes were detected in 4 isolates. The sfa and pap virulent genes were founds in 26% and 22% of isolates receptively. The genotyping analysis of all strains revealed that almost were belonged to phylogenetic groups A1 and A0 and fourteen distinct clones. Conclusion: The emergence of uropathogenic ESBL isolates and the high rate of blaCTX-M are alarming in Algeria. Strict measure must be required to control the further spread of these strains in Algerian hospitals.
Introduction
Extended-spectrum β-lactamases (ESBL) are enzyme identified frequently in E. coli and Klebsiella pneumoniae and responsible for resistance against penicillins, cephalosporins and aztreonam [1] . The ESBL-producing E. coli have widely caused the nosocomial infections which associated with high mortality rates and health care costs [2] . The pathogenicity of these strains is mainly induced by gene-encoding virulence factors, such as adhesion and biofilm formation, production of toxins, and polysaccharide surface coatings.
Urinary tract infections (UTIs) are common diseases in the world, especially for women which occurring in 10% to 20% during their lifetimes [3] . These infections are caused largely by E. coli [4] . The phylogenetic analysis of pathogenic ESBL-producing E. coli strains revealed that almost all afield to group B2 and, to a lesser extent, group D. Several studies founded that risk factors involved hospital acquired UTIs, include prolonged hospital stay, older age and gender, comorbidity, prior use of antibiotics and frequent use of health resources. ESBL-producing E. coli strains are frequently exhibit a multidrug-resistant phenotype, which includes resistance to aminoglycosides and fluoroquinolones [5] . This multidrug resistance making UTIs therapy difficult and promoting greater use of expensive extended spectrum antibiotics.
In correlation with an extensive use of β-lactam antibiotics over the last decades, various β-lactamases types and mutants have emerged in hospital and community settings. Initially, the first ESBLs identified
Methodology

Setting
This study was conducted at the Universityaffiliated hospital of Tlemcen (public institution) located in Tlemcen city (situated at 600 km west of the capital Algiers), with 800 bed teaching hospital distributed in 25 medical and surgical units, including two adult intensive care units (ICUs) with a total of 14 beds. The university-affiliated Hospital of Tlemcen, receives approximately 136,000 patients for consultations and 6000 admissions per year.
Data collection and bacterial strains
All the hospitalized patients presenting UTI and infected by E. coli from January 2011 to December 2013 were included. The medical records of these patients were retrieved and reviewed. Information was obtained about basic demographic characteristics (age, sex and pre-infection hospital stay) as well as comorbid diseases (surgical intervention, renal diseases, respiratory diseases, central nervous diseases, and others), use of urinary catheters, intensive care unit admission, previous hospitalization, and length of hospital stay. The diagnosis of nosocomial infection was established according to the Center for Disease Control (CDC) criteria.
Previous hospitalization was defined as hospitalization at University-affiliated hospital of Tlemcen within 30 days prior to the current admission. Recent surgery was defined as any surgical procedure performed in the operating room within 30 days of entry in the study. The origin of isolate was accepted as nosocomial if the strain was isolated more than one week after hospitalization.
E. coli isolated from urine were identified using API 20E system (Biomerieux, Marcy l'Etoile, France). Prior to their testing, all the isolates were stored in 15% glycerol-supplemented Luria-Bertani medium (BioRad, Marnes-la-Coquette, France) at -80°C.
Antimicrobial drug susceptibility testing
Antimicrobial drug susceptibility was determined by the disk-diffusion method on Mueller-Hinton (MH) agar plates (HiMedia, Mumbai, India), as recommended by the CLSI [7] . The following antimicrobial agents (Bio-Rad, Marnes-la-Coquette, France) were tested: amoxicillin (25 μg), amoxicillin/ clavulanic acid (30 μg), ticarcillin (75 μg), ticarcilline/ clavulanic acid (85 μg), piperacillin (75 μg), piperacillin/ tazobactam (85 μg), cephalotin (30 μg), cefotaxime (30 μg), ceftazidime (30 μg), cefepime (30 μg), imipenem (10 μg), aztreonam (30 μg), cefoxitin (30 μg), gentamicin (15 μg), amikacin (30 µg), nalidixic acid (30 μg), and ciprofloxacin (5 μg).
Multidrug-resistants (MDR) were defined as those resistant to at least two of the antibiotic classes in addition to the β-lactams. E. coli ATCC 25922 (American Type Culture Collection, Manassas, USA) was used as quality control strain.
Phenotypic detection of ESBL production
According to CLSI guidelines [7] , the ESBL production was detected by the double-disc synergy test using cefotaxime (30 μg) disks, with and without clavulanic acid (10 μg). The E. coli test strains were inoculated into Mueller-Hinton agar at a 0.5 McFarland standard, followed by incubation at 35°C for 16 to 18 hours. Diameters of inhibition zones were measured with a standard caliper (Flower Company Inc., Newton, MA, USA). A difference in inhibition zones of ≥5 mm for cefotaxime-clavulanic acid combination versus the corresponding cefotaxime alone was considered indicative of ESBL production.
The standard strains E. coli ATCC 25922 and K. pneumoniae ATCC 700603 (American Type Culture Collection, Manassas, USA) were used as negative and positive controls of ESBL production, respectively.
Preparation of DNA template for PCR
DNA templates for Polymerase Chain Reaction (PCR) process were generated by suspending 5 colonies of an overnight culture of E. coli isolates growing on Luria Bertani agar (Bio-Rad, Marnes-la-Coquette, France) in 500µL of DNase-and RNase-free water (Invitrogen, Paisley, UK). The suspension was boiled at 100°C for 10 minutes in thermal block (Bioblock Scientific, Illkirch, France), then centrifuged at 19000g for 5 minutes. An aliquot of 1 µL of the supernatant was used as DNA template for PCR
Detection of β-lactamases encoding genes
All ESBL-producing E. coli isolates were screened by PCR for the following β-lactamase-encoding genes: bla CTX-M phylogenetic lineage groups 1, 2, 8, 9 and 25, bla TEM , bla SHV , bla OXA , bla PER and bla VEB genes as described by Barguigua et al. [8] . ESBL-producing E. coli resistance to cefoxitin antibiotic were further tested by using primers specific for plasmid-mediated AmpC β-lactamases encoding genes as described by Pérez-Pérez and Hanson [9] .
Detection of plasmid mediated quinolone resistance genes
All ESBL-producing strains were screened by multiplex PCR for qepA and qnr genes (qnrA, qnrB, qnrD, qnrC and qnrS) as previously reported [8] . PCR amplification of aac(6')-Ib-cr, a fluroquinolonemodifying aminoglycosid acetyltransferase, was performed using primers that amplify all aac(6')-Ib variants. Isolates positive for aac(6')-Ib were sequenced to identify aac(6')-Ib-cr as described by Barguigua et al. [8] .
Detection of 16S rRNA methylase genes
To detect 16S rRNA methylase gene alleles (armA, rmtA, rmtB and rmtC), all ESBL producers isolates that were resistant to gentamicin or amikacin were included for study. The PCR primers and method used were as previously reported [10] .
Detection of virulence genes
Multiplex PCR was used for the amplification of genes encoding pyelonephritis associated pili (pap genes), S-family adhesions (sfa gene), hemolysin (hly gene), and cytotoxic necrotizing factor 1 (cnf1) as previously described [11] .
Phylogenetic genotyping
Phylogenetic grouping of the E. coli isolates was determined by a PCR-based method developed by Clermont et al. [12] [13] .
All primers used in this work are shown in Table 1 .
Sequencing of resistance genes
All amplified products obtained were sequenced to validate their identities. Both strands of the purified amplicons were sequenced with a Genetic Analyzer 3130×1 sequencer (Applied Biosystems, Foster City, CA, USA), with the same primers used for PCR amplification. The nucleotide and deduced protein sequences were analysed with software available over the Internet at the National Center for Biotechnology Information website (www.ncbi.nlm.nih.gov).
Enterobacterial repetitive Intergenic Consensus (ERIC)
ERIC analysis was performed using the primer ERIC-2 as previously reported [14] . Each PCR reaction was carried out in a 25 μL volume using 1.5 U of Taq DNA polymerase (Promega, Madison, Wis, USA) in the reaction buffer provided by the manufacturer containing 2.5 mM of MgCl 2 , 50 μM of each deoxynucleoside triphosphate, 0.3 μM of the selected primer and 5 μL of the DNA template. Aliquots (10 μL) of each PCR product were subjected to an electrophoresis on 1.5% agarose gel.
Statistical analyses
The relation between the ESBL-producing E. coli strains and possible risk factors was evaluated according to the epidemiological data collected.
Table1. Primers used for PCR amplification.
Gene Primer Primer sequence (5'→3')* Reference
Data were entered into a database using the SPSS 20.0 for Windows (SPSS Inc, Chicago, USA), the χ 2 test and the independent sample t test was used for categorical and continuous variables, respectively. A stepwise multivariate logistic regression was conducted to examine the association of risk factors controlling for potential confounders. The logistic model included all variables for which a p value of < 0.1 was obtained in the multivariate analysis. A p value of < 0.05 was considered as significant.
Results
A total of 441 patients having symptomatic UTIs were included in this study. (Figure 1 ). The median age was 40 in the ESBL group and 36 in the non-ESBL group, with no significant difference, using parametric (for mean) or non-parametric (for median) tests. The duration of hospitalization was slightly different between the groups (ESBL and non-ESBL), although it had a tendency to be prolonged in the non-ESBL group ( Table 2) .
The most common coexisting disease in two groups (ESBL and non-ESBL) included the diabetes, cancer and hypertension. Among the ESBL group, the frequency of previous hospitalization (55.5%) was higher than non-ESBL group (41.07%). Even though several variables were compared (ESBL vs. non-ESBL), central venous catheter use was statistically significant ( Table 2 ). In the multivariate analysis, none of the risk factors for ESBL were identified.
The antimicrobial susceptibility testing was done by disc diffusion method to 83 clinical isolates of E. coli. The resistant rates for β-lactam antibiotics including amoxicillin, ticarcillin, cefalotin, piperacillin and amoxicillin/clavulanic acid were more than 64% in all tested clinical strains. The resistant rates for non-β-lactam antibiotics including nalidixic acid, gentamicin, ciprofloxacin, and amikacin were 38.55%, 22.89%, 21.68% and 18.07%, respectively.
The degrees of antibiotic resistance for all antibiotics tested were significantly higher in the ESBL isolates, compared with non-ESBL isolates ( Table 4 . The bla CTX-M-15 (n = 25) was the most frequently detected in ESBL isolates, followed by bla CTX-M-14 (n = 2), bla CTX-M-28 (n = 1), bla CTX-M-1 (n = 1) and bla (n = 1) respectively. Three ESBL isolates were identified harbouring two ESBL genes with bla CTX-M-15 + bla CTX-M-14 (n = 2), bla CTX-M-15 + bla (n = 1) combination. None of the ESBL isolates gave positive PCR results for ESBL encoding genes; bla PER , bla VEB and bla CTX-M phylogenetic lineage groups 2, 8 and 25. The bla TEM-1 was detected in 26 (96%) of ESBL strains.
The cephalosporinases CMY-2 and MOX types were found in two ESBL isolates. These genes has been presented with the following combinations: bla CMY-2 + bla CTX-M-15 + bla TEM-1 and bla MOX + bla CTX-M-15 + bla TEM-1 .
The PMQR genes were found in the 15 ESBL strains examined with the aac(6')-Ib-cr gene (n = 13) was the most detected followed by qnrB1 (n = 4) and qnrA1 (n = 1) gene respectively (Table 4) . Three isolates of ESBL producers were co-harboured two PMQR genes with the following combination: qnrB1+ aac(6')-Ib-cr (n = 2) and qnrA1+aac(6')-Ib-cr (n = 1).
Among the 22 ESBL isolates resistant to gentamicin and amikacin, the 16S rRNA methylase genes were detected in 4 isolates (18.18%). The armA+ rmtB combination was found in two isolate and armA alone in others two strains (Table 4) .
The research of virulence factors such as pap, sfa, hly, and cnf1 by the multiplex PCR showed that the prevalence of virulent genes ranged from 4% to 26%: 4% for cnf1, 22% for pap and 26% for sfa. The phylogenetic analysis of all ESBL strain revealed that almost of the strains studied were belonged to groups A1 (n = 9) and A0 (n = 6), followed by B1 (n = 5), B2 (n = 6) and D1 (n = 1).
In the genotyping analysis, the ERIC-PCR patterns of the ESBL-producing isolates revealed fourteen distinct clones (Table 4) . Nine of these clones (clones A, B, G, J, K, N, O, P and Q) were represented by a single isolate. Clone F was represented by four strains (ec12, ec9, ec10 and ec11) isolated from old male patients hospitalized in urology ward. Clones C (4 strains) and clone E (3 strains) were mostly represented by strains identified in maternity ward. The patients hospitalized in the internal medicine were frequently infected by strains included in clone H (4 strains) and clone I (2 strains).
Discussion
At university-affiliated hospital of Tlemcen, the rate of UTIs is much noticed in the maternity and urology wards. The recognized risk factors of UTIs in the literature were feminine sex, age over 65 years, and a recent hospitalization under six months [15, 16] . In contrast other studies showed that there are no significant difference between men and women [15, 16] . However these results are concordant with those obtained in this study, which we found that diabetes is no longer considered a risk complicating factor p ≤ 0.001 [15, 16] . Other causes may play an important role in UTIs such the non-compliance to hygiene rules, notably washing and hand disinfection by health care personnel, which is an important risk factor for the transmission of nosocomial infections.
In recent years, the increase of antibiotic resistance has threatened the entire world. The production of -lactamase, which hydrolyses and inactivate -lactam antibiotics, become one of the most important resistance mechanisms of several bacterial species, mainly in Enterobacteriaceae family. Bacterial resistance to extended spectrum -lactam antibiotics is increasingly associated with ESBL [17] .
The overall prevalence of ESBLs production varied considerably according to geographic areas and hospital structures. ESBLs prevalence rate in this study is still strong compared to that reported in northern Algeria (19.9%) [18] and Tunisia (20.2%) [19] . However, higher prevalence rates of ESBLs produced by K. pneumoniae were detected in South America (45.4% to 51.9%) [20] and Saudi Arabia (55%) [21] . The current study showed that E. coli was the commonest cause of UTIs (62%) followed by K. pneumoniae. The prevalence of ESBL-producing E. coli stains was 32%. This high rate of ESBL producing E. coli at universityaffiliated hospital of Tlemcen could be attributed to the indiscriminate and widespread use of antibiotics, particularly -lactam antibiotics which are sold over the counter in pharmacy shops without doctors' prescription.
In this study, antibiotics susceptibility tests showed that ESBL producing E. coli isolates were susceptible to imipenem and were significantly multi resistant to all others antibiotic tested ( Table 2) . Rare use of imipenem in the hospital of Tlemcen could explain the high susceptibility to this antibiotic.
The sensitivity of Enterobacteriaceae to ß-lactam antibiotics showed high levels of acquired resistance in these bacteria, especially in hospital setting, mainly due to the extensive use of -lactam antibiotics, which cause a selection pressure of resistant strains. In addition, these resistance are also due to plasmids transfer between pathogens [22] . In contrast, Aminoglycosides and Fluoroquinolones antibiotics have an excellent activity against ESBLs producers Enterobacteriaceae [23] .
The vast majority of E. coli strains isolated in our study are sensitive to imipenem, however amoxicillin and cephalothin are frequently resistance because it is the most prescribed in the local market.
The most strains of ESBL-producing E coli were resistant to gentamicin, and ciprofloxacin; it supports the work of Tolun et al. [24] and Alhambra et al. [25] . The mechanisms of this resistance are not yet clearly established, but some authors suggest the cotransmission ESBL and other antibiotic resistance genes by the same conjugative plasmid [22] .
In this study, amongst the 27 CTX-M-producing E. coli isolates, CTX-M-15 was the major ESBL (25 isolates) followed by CTX-M-14 (2 isolates). CTX-M-14 and CTX-M-15 enzymes were commonly detected in Algerian hospitals [26, 27] . Many studies have reported that CTX-M-15 type enzymes were the predominant type of ESBL in hospital-acquired UTIs [28, 29] . Most of the ESBL-Enterobacteriaceae isolates were resistant to the other classes of antibiotics, in particular fluoroquinolones, which are commonly prescribed by general practitioners against UTIs. However, increased fluoroquinolones resistance has now been associated with ESBL isolates [29] . This increase has apparently occurred in parallel with the emergence of plasmid-mediated fluoroquinolone resistance mechanisms [30] . Furthermore, our study has revealed the presence of plasmid-mediated broadspectrum resistances co-existing with ESBLs, such as qnrB, qnrS and aac(6')-Ib-cr which confers quinolone resistance.
Several studies have shown a close association between the CTX-M and qnr determinants. Iadadene and al. [27] revealed in their study, the co-producing of qnrB1 and qnrS1 with CTXM-15 and SHV-12 in Algerian isolates of E. cloacae. The presence of qnr and aac (6')-Ib-cr genes in clinical isolates of E. coli and K. pneumoniae has been reported worldwide [22, 30] . A large number of studies have also shown the presence of qnr genes along with resistance to various β-lactamase, including the AmpC and ESBL [27, 31] . In Algeria, it was detected for the first time in 2009 in a strain of E. cloacae [32] and among Enterobacteriaceae strains in the community [33] . The prevalence of aac(6')-Ib-cr in our study is in agreement with previous studies reporting high rates of the aac(6') allele and its association with ESBL, particularly CTX-M [34, 35] .
The majority of E. coli strains positive for aac(6')-Ibcr were often co-expressed an ESBL CTXM-1 (75 %). There is one other study from Iran which reported the high prevalence of PMQR genes (qnrA and qnrB but not qnrS) in E. coli [36] .
The remaining PMQR determinants are rarely detected in E. coli in the UK, as confirmed by the low detection rates of qnrS (1.1 %), qepA (1.1 %) and oqxAB (0.6 %) [35] . Previous studies have reported that PMQR genes are more common in Klebsiella species in the UK than in E. coli, but that they are most frequent in E. coli in East Asia [37] . In Algeria, qnr genes (A, B, S) were detected in hospital ESBLs-producing Enterobacteriaceae strains (CTX-M, SHV-12 and VEB-1) [27, 38] . More recently, qnr genes were detected in E. coli strains producing CTX-M responsible for UTIs in Bejaia (Algeria) [33] . AmpC have been found worldwide but are less common than ESBL [39] . They are emerging worldwide in several Gram-negative bacteria as a mechanism of resistance to cefoxitin. In our study, two cefoxitin-resistant ESBLproducing isolates were carried plasmid-mediated AmpC. In Algerian and England hospitals the reported prevalence of AmpC was 1% and 7.15 %, respectively [40, 41] .
In our study, E. coli isolates were mainly groups A 0 , A 1 B 1 , B 2 and D 1 strains usually commensal strains, while phylogenetic groups A and B 2 strains, which are commonly extra-intestinal pathogenic were less frequent. We found also, that the prevalence of virulent genes ranged from, 4% to 26% for sfa. Moreover, the rate of virulence genes in Romanian uropathogenic E. coli strains was 86%, 36%, 23%, 14% for fimH, papC, sfa/foc, and afa respectively [42] . Many virulence factors facilitate E. coli invasion in to the vascular system causing bacteraemia and many other deepseated infections [43] .
Nosocomial urinary tract infections are responsible for significant morbidity, more predisposing factors such infections. Accurate knowledge of stem isolated bacterial during a resurgence of infections in a hospital unit, beyond the species identification and antibiotic susceptibility testing routine, has become a necessity to identify the mode of transmission of the bacteria to the host. The phenotypic usual have limitations. If a number of phenotypic traits allow define bacterial species, the expression of phenotypic traits may vary living conditions for the bacteria.
The bacterium that seems constantly feel its environment, activates or inhibits some of its genes so as to be congruent therewith. This raises a problem the reproducibility of the results can be embarrassing for a series of comparisons strains, if one is based on phenotypic traits.
The ERIC-PCR showed the presence of 14 clones among 27 ESBL-producing E. coli isolates. Moreover, the fact of finding the same clone of the 2013 and 2012 strains us indicates that the situation is old and it persists, mainly in intensive care and medicine.
The sequencing of the PCR products of 27 E. coli strains isolated at Hospital Tlemcen Algeria helped to highlight the production of three types of ESBLs, with a clear predominance of CTX-M type ESBLs, especially CTX-M-15, or 92.59%.
These results agree with those reported by previous studies carried out in Algeria [27] , Tunisia [44] , Morocco [8] , Nigeria [45] , Mali [46] and numerous countries worldwide [47, 48] .
Conclusion
Our study reports the occurrence of ESBL genes in uropathogenic multidrug-resistant E. coli from hospitalized patients in an Algerian hospital. These isolates carried others β-lactamases and other resistance determinants such as PMQRs and 16S rRNA methylase genes. This is alarming as spread of these isolates will seriously limited options for clinical treatment in future. We hope that this phenotypical and molecular resistance data will help clinicians to better define the empiric treatment of UTIs caused by multidrugresistant E. coli and to minimize the opportunity for their clonal diffusion.
